Multimodal AI poised to revolutionize cardiovascular disease diagnosis and treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Dec-2025 08:11 ET (14-Dec-2025 13:11 GMT/UTC)
An international team of researchers has reviewed the latest advances in multimodal artificial intelligence (AI) for cardiovascular diseases (CVD), highlighting its superior diagnostic accuracy, risk prediction, and therapeutic guidance compared with traditional single-data approaches. The review outlines how integrating imaging, genomics, electronic health records, and wearable data into unified AI models can enable earlier diagnosis, personalized therapy, and continuous remote monitoring, heralding a new era of precision cardiology.
A large-scale genetic study comparing Chinese and UK patients with hypertrophic cardiomyopathy (HCM) reveals significant ethnic differences in rare variant burden and specific mutations, highlighting the need for ancestry-aware genetic diagnostics and personalized medicine.
AlphaFold 3 (AF3), the latest AI model from Google DeepMind and Isomorphic Labs, can predict the structures and interactions of nearly all biomolecules with unprecedented accuracy, opening new avenues for drug design, vaccine development, and precision medicine.
A 6-year cohort study conducted by researchers from Japan, comprising nearly 39,000 older adults found that people living in rental flats and owner-occupied detached houses face higher risks of cardiovascular death compared with those in owner-occupied flats. The study attributes to the increased risk to colder, less stable indoor temperatures in these housing types and suggests that improving housing quality to address these issues could lower cardiovascular mortality, particularly among men.
Relative weights analyses showed the neglect/interference/punishment domain contributed most significantly (28.78%) to behavior problems in preschool children with developmental disabilities.